T. Daniels

Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor–tezacaftor–ivacaftor therapy

Helen Gavillet, L. Hatfield, Ryan Marsh, G.G. Einarsson et autres

gb, ca, us (code pays fourni par la source)

Nontuberculous mycobacteria remodel lung microbiota in cystic fibrosis-associated respiratory infections

S.A.H. Higgi, Liam Hanson, Kristin C. Schutz, Matthew J. Wargo et autres

gb, us (code pays fourni par la source)

WS08.03Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor/tezacaftor/ivacaftor therapy

Helen Gavillet, L. Hatfield, Matthew J. Hardman, G.G. Einarsson et autres

gb, ca, us (code pays fourni par la source)

Corrigendum to “Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework” [Respirat. Med. 239 (2025)]

Robert D Sandler, Alan Anderson, Tracy Barnett, Stephen Bourke et autres

gb (code pays fourni par la source)

Peripheral Muscle Function and Body Composition in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A Cross‐Sectional Single‐Centre Study

L J, Anthony I. Shepherd, Jo Corbett, Mathieu Gruet et autres

gb, fr (code pays fourni par la source)

The FHJ debate: Sustainable healthcare should be the responsibility of every physician

T. Daniels, Linford Fernandes

gb (code pays fourni par la source)

Optimising outcomes for adults with cystic fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework

Robert D Sandler, Alan Anderson, Tracy Barnett, Stephen Bourke et autres

gb (code pays fourni par la source)

Cardiovascular function in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A cross-sectional, observational, single-centre study

L J, Anthony I. Shepherd, Jo Corbett, Maria Perissiou et autres

gb (code pays fourni par la source)

Peripheral muscle function and body composition in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: a cross-sectional, observational, single-centre study

L J, Anthony I. Shepherd, Jo Corbett, Mathieu Gruet et autres

gb, fr (code pays fourni par la source)

Maternele en obstetrische uitkomsten in vrouwen met mucovisidose: een retrospectieve case series van patiënten uit UZ Leuven

T. Daniels, Kristel Van Calsteren, Lieven Dupont

WS09.01 Impact of long-term elexacaftor/tezacaftor/ivacaftor therapy on lung infection microbiota in adults with cystic fibrosis

Helen Gavillet, L. Hatfield, T. Daniels, A. Horsley et autres

gb (code pays fourni par la source)

P454 Body composition and peripheral muscle function in people with cystic fibrosis established on elexacaftor/tezacaftor/ivacaftor

Laura D. Clayton, Anthony I. Shepherd, Jo Corbett, Mathieu Gruet et autres

gb, fr (code pays fourni par la source)